Company Overview of Calyxt, Inc.
Cellectis Plant Sciences Inc operates as a subsidiary of Cellectis.
1000 Westgate Drive
St Paul, MN 55114
Key Executives for Calyxt, Inc.
Vice President of Finance and Investor Relations
Director of Communications
Compensation as of Fiscal Year 2015.
Calyxt, Inc. Key Developments
Calyxt Completes Second Year of Field Trials of High Oleic Soybean Product
Nov 2 15
Calyxt, Inc. announced that it has completed the second year of multi-location field trials in Minnesota and South Dakota of its high oleic/no trans fat soybean variety. For many food applications, standard soybean oil is hydrogenated to improve heat stability and shelf life. This process also increases the amount of saturated fatty acids and creates trans-fats, which have been linked to numerous human health issues. Calyxt has created a non-transgenic variety of soybean with elevated levels of monounsaturated (oleic) fatty acids and decreased levels of saturated fatty acids (palmitic and acid) and polyunsaturated fatty acids (linoleic and linolenic). Compared to standard soybean oil, the Calyxt soybean variety generates oil that eliminates the need for hydrogenation. The oleic acid content (81%) achieved in Calyxt's high oleic soybean variety is equal to or exceeds the oleic acid level of transgenic, high oleic soybean varieties currently being grown in the U.S. In addition, the yield of the Calyxt variety in these field trials was equivalent to current conventional varieties, putting Calyxt on the road for a commercial launch of its non-transgenic variety in the next couple of years. Counter-season seed production is currently underway to facilitate a commercial launch in the U.S. while additional field trials are conducted over the next few growing seasons.
Calyxt, Inc. Signs Exclusive License Agreement with Plant Bioscience Limited
Jul 15 15
Calyxt, Inc. announced that it has signed an exclusive license agreement with Plant Bioscience Limited for a bread wheat trait generated using gene editing. The trait provides endogenous resistance to powdery mildew of wheat, a fungus widely distributed throughout the world, responsible for major grain and yield losses.
S&W Seed Company and Calyxt, Inc. Announce Alfalfa Seed Collaboration
Jun 9 15
S&W Seed Company and Calyxt, Inc. announced that they have entered into a collaboration agreement to research, develop, produce and commercialize alfalfa seed products involving next generation gene editing technology on S&W's alfalfa seed genetics. Calyxt's technology allows for the custom gene-editing of plant species to create novel traits and increase value. In particular, Calyxt will be applying its patented nuclease technology to develop a series of alfalfa seed products based on editing of native genes to improve the agronomic and quality value of alfalfa for the food and agriculture industries. The approach is based on the same principle as classical cross-breeding of different plants, however the gene editing technology developed by Calyxt dramatically accelerates the development timeline. The targeted approach of gene editing is more predictable and reliable than traditional breeding and can also be much more cost effective. The companies will look to commercialize products through S&W and Calyxt's distribution channels with pre-defined financial terms.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries